US Patent Family Members and Approved Drugs for European Patent Office Patent: 1692282
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: EP1692282
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 8,288,127 | 2044-05-16 | asparaginase erwinia chrysanthemi (recombinant)-rywn | Jazz Pharmaceuticals Ireland Limited | RYLAZE |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
